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Resident microorganisms, known as the microbiota, are essential for many physiological functions 
including protection against pathogens. Microbiota is indeed required for proper immune system 
development and function, and can also host-independently protect against infections. Thus, a co-
constructed view of host defense involving both host and microbiota, named “co-immunity”, has been 
proposed, and the idea of an “immunological holobiont” has been suggested. Yet this view of co-
immunity might be too limited, as experimental work has shown that the immune system is involved 
in functions other than defense, essentially development and repair. Microbiota, through co-
immunity, is thereby most likely involved in these functions, although strong evidence is currently 
lacking. Moreover, as our point of view is mainly host-centered, we may miss the implications of co-
immunity at broader scales, including cellular and populational levels. Intriguingly, co-immunity effects 
could be beneficial for one function and/or one level, while detrimental for others. All these elements 
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1. Introduction: From immunity against microbes to co-immunity between hosts and microbes  
Microorganisms have long been seen as intrinsically and essentially harmful, and therefore as entities 
against which potential hosts must protect themselves. This has led to the concept that organisms 
isolate themselves from their microbial environment, and are protected against such microbial threats 
by their immune system, understood as a “defense” system (Burnet 1962; Clark 2008). Yet resident 
microorganisms are now clearly recognized as an integral and crucial part of our protective system 
against pathogens. Commensal bacteria, viruses, fungi and helminths can indeed protect their hosts 
against a variety of pathogens (Buffie and Pamer 2013; Belkaid and Hand 2014; Pamer 2016). We have 
recently proposed to label “co-immunity” this host-microorganism partnership ensuring host defense 
(Chiu et al. 2017).  
In this short essay, we present our main arguments in favor of the idea of co-immunity, before showing 
that this concept must be expanded in two main directions, namely the influence of the microbiota on 
non-defensive immune activities, and on multiple levels of immune responses. 
A few remarks about the vocabulary used in the present paper are in order. We define “microbiota” 
as all the resident microorganisms living in or on a host, regardless of the nature of their ecological 
interaction (parasitic, commensal, and mutualistic) with the host, their size, or taxonomic category 
(bacteria, viruses, fungi, or parasites such as helminths). In addition, we understand the notion of 
“holobiont” physiologically, as the collective entity composed by the host and its resident microbiota 
and displaying functions realized jointly by the host and the microbiota (Chiu and Eberl 2016; Pradeu 
2016). We do not claim that this collective entity is an evolutionary unit, contrary to the dominant (and 
disputed) use of the term “holobiont” (Vandenkoornhuyse et al. 2015; Bordenstein and Theis 2015; 
Douglas and Werren 2016; Skillings 2016; Doolittle and Booth 2017; Roughgarden et al. 2017), though 
it could qualify as an ecological unit (Hester et al. 2016). Moreover, the crux of our arguments concerns 
the details of how the microbiota influences immunity, and these arguments applies to the intimate 
association between a host and its microbiota, whether or not one considers that such association 
qualifies as “holobiont”. 
 
2. What is “co-immunity”? 
In a recent paper (Chiu et al. 2017), we have proposed the concept of “co-immunity”. This concept 
builds on previous knowledge about the potentially protective role of the microbiota, but makes also 
several steps further. 
Recent work has distinguished two main modes of microbiota-induced protection: a direct one via 
microbe-to-microbe interactions and an indirect one via activation by the microbiota of host’s immune 
system. For instance,  probiotic Escherichia coli Nissle 1917 directly outcompetes commensal and 
pathogen Escherichia coli and Salmonella Typhimurium via micromicin secretion (Sassone-Corsi et al. 
2016), while protozoan Tritrichomonas musculis indirectly protects from gut S. Typhimurium infection 
through the promotion of inflammatory Th1 and Th17 type immunity (Chudnovskiy et al. 2016). These 
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two modes of protection are grouped together under the concept of “colonization resistance”, which 
refers to all forms of host-dependent or host-independent resistance to pathogens that is induced by 
the microbiota. 
Still, this classic concept of microbiota-induced protection is too narrow for two reasons: on the one 
hand, the concept of colonization resistance is generally limited to a single defense strategy, that is the 
resistance against pathogen’s establishment and growth; on the other, protective effects are limited 
to the immediate vicinity of protective microbes. Thus, colonization resistance seems too limited to 
embrace the variety and the complexity of microbiota-mediated protective effects.  
First, other protective mechanisms than colonization resistance exist, namely containment and disease 
tolerance. Containment is the controlled localization of microbes within a particular site inside the 
host. For instance, in various organisms, bacteriophages that adhere to mucus glycoproteins can 
prevent translocation of bacteria, thus providing a host-independent localized protection of mucosal 
surfaces against bacterial infections (Barr et al. 2013). Disease tolerance is the limitation of host’s tissue 
damages induced by pathogens, without pathogen elimination. As an illustration, Bacteroides fragilis 
in the gut affects systemic T-cell responses through the action of the bacterium-derived polysaccharide 
A, which protects against pathobiont Helicobater hepaticus colitis via the production of anti-
inflammatory IL-10 by CD4+ T cells and the promotion of regulatory T cells, without any effect on 
pathogen fitness or load (Mazmanian et al. 2008). 
Second, microorganisms in one organ (mainly the gut) can influence immune responses in other 
organs. Long-reaching protective effects are less documented than local effects in the scientific 
literature, but convincing examples exist. For instance, mice challenged with pulmonary staphylococcal 
infection but lacking segmented filamentous bacteria in their gut microbiota show more severe 
infection with higher bacterial load and mortality, associated with diminished lung concentration of 
Th17 immune effector cells. Reintroduction of segmented filamentous bacteria is sufficient to restore 
protective effect (Gauguet et al. 2015). 
Thus, we propose a systematic classification of protective mechanisms that includes a broader range 
of defensive strategies than localized colonization resistance, distinguishing the modes (direct or 
indirect), the ranges (localized or long-reaching) and the effects (mechanisms) of protection (see Figure 
1). The notion of co-immunity that we propose (i.e., a form of immune defense associating 
components of several organisms), which in the present contexts combines components of the host 
and of the microbiota, includes all these different modes, ranges, and effects. 
 
3. Enriching the concept of co-immunity in terms of activities and levels 
Despite the encompassing nature of the concept of co-immunity, we think it is still too limited, and 
must therefore be expanded in two main directions. First, immunity is not limited to defense 
strategies, and taking this fact into account extends significantly the implications of the concept of co-
immunity. Second, co-immunity might concern other levels than that of the individual organism. 
a. Co-immunity beyond defense 
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We previously defined co-immunity as a form of immune defense (Chiu et al. 2017). But what does 
“defense” exactly mean in this context? If we agree that to defend means to fight or to help to fight 
against an external aggression, which is the commonly accepted definition, colonization resistance and 
containment can be considered as defense mechanisms, acting as “knights” – either using a “shield” 
(protection) or a “sword” (attack). But should disease tolerance be always considered as a defense 
mechanism? In the case of the inhibition of pathogenic toxins, for instance (de Sablet et al. 2009), it 
might be said so. But the toleration (rather than the destruction) of pathogens can be a cost-effective 
alternative when upkeep of pathogen fitness does not strongly decrease host fitness (e.g., when 
pathogen virulence is low), especially since the side effects of aggressive inflammatory immune 
responses are sometimes more damaging to the host than the “infection” itself. For instance, gut 
commensal Escherichia coli O21:H+ antagonizes muscle wasting during Burkholderia thailandensis or 
Salmonella Typhimurium infections, without a negative impact on the fitness of these pathogens 
(Schieber et al. 2015). In this precise case, disease tolerance could act more like a wise gate-keeper 
than like a knight, away from a strictly speaking defense action, and sometimes paving the way for a 
potentially mutualistic relationship. 
Moreover, we know that immunity is implicated in many other activities than protection alone. The 
immune system plays indeed a key role in robustness, that is the capacity for each organism to develop, 
defend, and repair (Laurent et al. 2017; Truchetet and Pradeu 2018). Could co-immunity be implicated 
in development-associated and repair-associated activities?  
The notion that animal development universally relies on microbial cues (developmental symbiosis) is 
gaining traction (Gilbert 2016). However, in most cases the three actors’ game between microbiota, 
immune system and development remains to be demonstrated, as for the most part what we have is 
correlations only. A much studied bacterial symbiosis in the animal world is the association between 
the squid Euprymna scolopes and the bacterium Vibrio fischeri, where a crucial step of the squid’s 
organogenesis relies on the presence of this particular bacterium. V. fischeri is specifically required for 
the E. scolopes’ light organ to fully develop, which is to lose its superficial ciliated field. This action is 
linked with a direct interaction between tracheal cytotoxin (a fragment of the peptidoglycan) released 
by V. fischeri and epithelium-lined crypts of the light organ (Koropatnick et al. 2004). Pathways 
explaining developmental effects distant from this specific epithelium probably involve macrophage-
like hemocytes that are recruited during V. fischeri colonization (McFall-Ngai et al. 2010), suggesting 
that in the present case organogenesis relies on the interaction between a specific bacterium and the 
animal’s immune system. Interestingly, microscopic examination of various squid tissues revealed that 
host hemocytes specifically migrate into the epithelial fields on the surface of the light organ before 
any signal of morphogenesis changes, suggesting a causal link between hemocyte modifications and 
organogenesis. Moreover, hemocyte gene expression correlates with the induction of light organ 
morphogenesis, suggesting that bacteria-induced molecular changes in the hemocytes are required 
for their developmental effects. However, direct impact of V. fischeri on hemocytes’ gene expression 
has yet to be demonstrated (Koropatnick et al. 2007). 
Microbiota in association with the immune system is also suspected to play a role in the development 
and the organization of the enteric nervous system (Obata and Pachnis 2016). For instance, in the 
network of murine enteric nervous system, mucosal glial cells develop in response to gut microbiota, 
but it is unclear whether this is a consequence of direct glia sensing of microbial factors, or if it is 
instead mediated by the immune system (Veiga-Fernandes and Pachnis 2017). In humans, the 
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microbiota is suspected to play a role in neurodevelopment, this having been particularly studied in 
autism (Kelly et al. 2017). Microglia development, maturation and function are influenced both 
prenatally and postnatally by the microbiota (Erny et al. 2015); as microglia contribute to brain 
development, microbiota could indirectly influence brain development (Thion et al. 2018), though 
more research is needed to entirely establish this claim.  
 
Concerning repair, some studies show a beneficial role of peculiar species in healing intestinal ulcers 
and cutaneous infections (Lukic et al. 2018), potentially through systemic effects of beneficial bacteria, 
whereas others point to an accelerated and scarless skin healing in germ-free conditions (Canesso et 
al. 2014). Interestingly, the three actors’ game between the microbiota, the immune system and repair 
processes have begun to be deciphered. A link between the microbiota and intestinal repair was 
suspected after the discovery that toll-like receptor (TLR) activation by microbiota components is 
needed to promote tissue repair and host survival following acute injury (Rakoff-Nahoum et al. 2004). 
Moreover, Lai et al. showed that lipoteichoic acid, produced by skin commensal Staphylococcus 
epidermidis, can bind to TLR 2, and thus mitigate inflammation, thereby promoting wound healing (Lai 
et al. 2009). More recently, Linehan et al. showed that a skin commensal can induce a specific T-cell 
response that accelerates skin wound healing, proving the implication of the immune system in 
microbiota modulation of tissue repair (Linehan et al. 2018). Notably, commensal-specific T-cells 
expressed repair signature genes and were different from pathogen-induced ones. 
Together, these results suggest that the boundaries of our conceptual framework need to be extended, 
and raise a new question: if a microbe can modulate different immune functions, is there a possibility 
that what we call a pathogen because of its deleterious effect on one function could be beneficial in 
another immune function? And, conversely, can a protective microbe for one function be deleterious 
for another function? The latter is crucial for safety of microbiota interventions. 
 
b. Co-immunity beyond the level of the organism 
Our vision of protection is usually centered on the level of the organism. Yet co-immunity could occur 
at different scales, both within and beyond the organism. This raises the question of whether 
pathogenic effects can impact differentially the various levels under consideration. 
At the populational scale, microbiota transmission could be implicated in social immunity in insects 
(Cremer et al. 2007), and in “herd immunity” (Fine 1993) in humans and cattle, whose prototypical 
example is vaccination. Social immunization, that is the interindividual transmission of protective 
properties against pathogens, is a part of social immunity and has been observed in termite 
Zootermopsis angusticollis (Traniello et al. 2002) and in Bombus terrestris bumblebee (Sadd et al. 
2005). Precise mechanisms are unknow, and cannot involve antibody transmission in invertebrate 
animals (Moret and Schmid-Hempel 2001). As microbiota transmission is strongly favored by sociality 
(Kwong and Moran 2016), it could be the vector of this sort of social immunity.  
In humans, the carcinogenic effect of Helicobacter pylori on gastric mucosa is well-known, but at the 
organism scale H. pylori infection is associated with a protection against tuberculosis (Perry et al. 
2010), which can hypothetically modify the transmission of infection at the population level. It is also 
plausible that a peculiar microbiota could protect one host from the damages induced by a pathogen, 
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for instance by inducing disease tolerance, thereby encouraging its growth and transmission and 
decreasing population’s fitness, though evidence for such a phenomenon is currently lacking. In the 
opposite way, a peculiar microbiota could increase community fitness, while disadvantaging 
predisposed hosts (altruistic immunity). 
Within a multicellular organism, it is perfectly plausible that a bacterium hosts a phage that protects 
the bacterium against pathogens (which means that there is a co-immunity between the bacterium 
and the phage), but this association weakens the immune protection of the multicellular host against 
a given pathogenic threat in a given context. It is also conceivable (though no evidence currently exists 
for this, to our knowledge) that an intracellular microorganism increases cell-intrinsic immunity (i.e., 
immunity at the level of a cell) (e.g, (Bieniasz 2004; Yan and Chen 2012; Ablasser et al. 2013)), at the 
expense of the immune response of the whole organism against a given pathogen. This could happen 
in plants, for example, where immunity is to a large extent dependent on cell-intrinsic processes, 
making the coordination of these cellular responses at the higher level of the organism quite 
complicated (Szittya and Burgyán 2013). Other interesting cases of conflicts between levels of co-
immunity could include organisms that transition from a unicellular to a multicellular stage, with the 
emergence of collective immunity at the multicellular level, like Dictyostelium discoideum (Chen et al. 
2007). Here again, one could imagine an intracellular symbiont favoring the immune protection of a 
cell within the multicellular slug, but detrimental to immune protection of the slug as a whole against 
a given pathogen. Though speculative, these considerations are plausible, and it is likely that the lack 






The immune system is so dependent on its interactions with the microbiota for its development and 
functioning that the “pure” eukaryote-only concept of immunity seems to progressively vanish. In 
parallel, “host-independent” immune protection is very relative, as microbiota composition is actively 
modulated by the immune system. Thus, a co-constructed view of immunity (according to which 
immunity is the product of the intricate contribution of both the host and the microbiota) is essential. 
The question can be raised as whether it is useful to continue to use the term “immunity” alone, or if 
this term should be completely replaced by that of “co-immunity” (see Figure 2). Considering 
protective immunity as a distinct physiological function and the holobiont as an individual, co-
immunity could give birth to the notion of a “immunological holobiont”, without again assuming that 
this entity constitutes an evolutionary unit (Pradeu 2016; Postler and Ghosh 2017). 
It might be possible to object to our argument here that the vision of the immune system as 
multifunctional is not consensual, and that evidence concerning development and repair mediated by 
a dialogue between the immune system and the microbiota is scarce. In response, we would say that 
recent research does seem to point in that direction and that, as philosophers and medical doctors 
involved in microbiota research, our aim is mainly to try to open up original avenues for future 
research. We suggest that testing the potential beneficial effects of a new bug should be accompanied 
by a broad reflection about its impact on all immune functions (not just defense), at different scales 
(not just that of the organism), and in different contexts. This expanded view of co-immunity should 
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also be combined with a switch from a host-centric view (as is usually the case in discussions over 
“holobionts”) to a microbe-centric view. This switch is likely to further enrich the co-constructed view 
of immunity that we have tried to propose in this essay. 
 
Figure 1. An expanded view of microbe-conferred protection. Microorganisms can protect the host in 
different ways, depending on the mode of protection (direct ecological and indirect host-mediated), 
the effects of protection (colonization resistance against pathogenic establishment and growth, 
containment of pathogens and their effects, and disease tolerance of pathogens while suppressing 
their negative effects), and the range of protection (localized or long-reaching, with the latter further 
divided into protection that is systemic or from one locale to another locale). All three aspects of 
protection can occur in combination. Long-reaching protection, for instance, involves both direct 
(ecological) and indirect (host-mediated) modes of protection that result in colonization resistance, 









Figure 2. Conceptual transition from colonization resistance as a peripheral part of our 
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